These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30180214)

  • 21. HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals.
    Omondi FH; Chandrarathna S; Mujib S; Brumme CJ; Jin SW; Sudderuddin H; Miller RL; Rahimi A; Laeyendecker O; Bonner P; Yue FY; Benko E; Kovacs CM; Brockman MA; Ostrowski M; Brumme ZL
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidences for viral strain selection in late stages of HIV infection: an analysis of Vpu alleles.
    Gondim MV; da Silva JX; Prosdocimi F; Leonardecz-Neto E; Franco OL; Argañaraz ER
    Protein J; 2012 Feb; 31(2):184-93. PubMed ID: 22237729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of the severe CD4+ T-cell loss caused by a pathogenic simian-human immunodeficiency virus by replacement of the subtype B vpu with the vpu from a subtype C HIV-1 clinical isolate.
    Hill MS; Ruiz A; Pacyniak E; Pinson DM; Culley N; Yen B; Wong SW; Stephens EB
    Virology; 2008 Feb; 371(1):86-97. PubMed ID: 17950774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional antagonism of rhesus macaque and chimpanzee BST-2 by HIV-1 Vpu is mediated by cytoplasmic domain interactions.
    Yoshida T; Koyanagi Y; Strebel K
    J Virol; 2013 Dec; 87(24):13825-36. PubMed ID: 24109238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell Surface Downregulation of NK Cell Ligands by Patient-Derived HIV-1 Vpu and Nef Alleles.
    Galaski J; Ahmad F; Tibroni N; Pujol FM; Müller B; Schmidt RE; Fackler OT
    J Acquir Immune Defic Syndr; 2016 May; 72(1):1-10. PubMed ID: 26656785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA Class I-Mediated HIV-1 Control in Vietnamese Infected with HIV-1 Subtype A/E.
    Chikata T; Tran GV; Murakoshi H; Akahoshi T; Qi Y; Naranbhai V; Kuse N; Tamura Y; Koyanagi M; Sakai S; Nguyen DH; Nguyen DT; Nguyen HT; Nguyen TV; Oka S; Martin MP; Carrington M; Sakai K; Nguyen KV; Takiguchi M
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression.
    van Stigt Thans T; Akko JI; Niehrs A; Garcia-Beltran WF; Richert L; Stürzel CM; Ford CT; Li H; Ochsenbauer C; Kappes JC; Hahn BH; Kirchhoff F; Martrus G; Sauter D; Altfeld M; Hölzemer A
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31375574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative Resistance of HLA-B to Downregulation by Naturally Occurring HIV-1 Nef Sequences.
    Mahiti M; Toyoda M; Jia X; Kuang XT; Mwimanzi F; Mwimanzi P; Walker BD; Xiong Y; Brumme ZL; Brockman MA; Ueno T
    mBio; 2016 Jan; 7(1):e01516-15. PubMed ID: 26787826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of apoptosis and viral latency - an axis to be well understood for successful cure of human immunodeficiency virus.
    Timilsina U; Gaur R
    J Gen Virol; 2016 Apr; 97(4):813-824. PubMed ID: 26764023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits its anti-tetherin activity.
    Lv M; Wang J; Wang X; Zuo T; Zhu Y; Kong W; Yu X
    PLoS One; 2011; 6(6):e20890. PubMed ID: 21674066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1.
    Brumme ZL; Brumme CJ; Heckerman D; Korber BT; Daniels M; Carlson J; Kadie C; Bhattacharya T; Chui C; Szinger J; Mo T; Hogg RS; Montaner JS; Frahm N; Brander C; Walker BD; Harrigan PR
    PLoS Pathog; 2007 Jul; 3(7):e94. PubMed ID: 17616974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 adaptation to NK-cell-mediated immune pressure.
    Alter G; Heckerman D; Schneidewind A; Fadda L; Kadie CM; Carlson JM; Oniangue-Ndza C; Martin M; Li B; Khakoo SI; Carrington M; Allen TM; Altfeld M
    Nature; 2011 Aug; 476(7358):96-100. PubMed ID: 21814282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weaker HLA Footprints on HIV in the Unique and Highly Genetically Admixed Host Population of Mexico.
    Soto-Nava M; Avila-Ríos S; Valenzuela-Ponce H; García-Morales C; Carlson JM; Tapia-Trejo D; Garrido-Rodriguez D; Alva-Hernández SN; García-Tellez TA; Murakami-Ogasawara A; ; Mallal SA; John M; Brockman MA; Brumme CJ; Brumme ZL; Reyes-Teran G;
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmitted/Founder HIV-1 Subtype C Viruses Show Distinctive Signature Patterns in Vif, Vpr, and Vpu That Are Under Subsequent Immune Pressure During Early Infection.
    Rossenkhan R; MacLeod IJ; Brumme ZL; Magaret CA; Sebunya TK; Musonda R; Gashe BA; Edlefsen PT; Novitsky V; Essex M
    AIDS Res Hum Retroviruses; 2016; 32(10-11):1031-1045. PubMed ID: 27349335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vpu binds directly to tetherin and displaces it from nascent virions.
    McNatt MW; Zang T; Bieniasz PD
    PLoS Pathog; 2013; 9(4):e1003299. PubMed ID: 23633949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV Triggers a cGAS-Dependent, Vpu- and Vpr-Regulated Type I Interferon Response in CD4
    Vermeire J; Roesch F; Sauter D; Rua R; Hotter D; Van Nuffel A; Vanderstraeten H; Naessens E; Iannucci V; Landi A; Witkowski W; Baeyens A; Kirchhoff F; Verhasselt B
    Cell Rep; 2016 Oct; 17(2):413-424. PubMed ID: 27705790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa.
    Hölzemer A; Thobakgale CF; Jimenez Cruz CA; Garcia-Beltran WF; Carlson JM; van Teijlingen NH; Mann JK; Jaggernath M; Kang SG; Körner C; Chung AW; Schafer JL; Evans DT; Alter G; Walker BD; Goulder PJ; Carrington M; Hartmann P; Pertel T; Zhou R; Ndung'u T; Altfeld M
    PLoS Med; 2015 Nov; 12(11):e1001900; discussion e1001900. PubMed ID: 26575988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic characterization of natural variants of Vpu from HIV-1 infected individuals from Northern India and their impact on virus release and cell death.
    Verma S; Ronsard L; Kapoor R; Banerjea AC
    PLoS One; 2013; 8(3):e59283. PubMed ID: 23555649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of HIV-1-host interaction: role of the Vpu accessory protein.
    Dubé M; Bego MG; Paquay C; Cohen ÉA
    Retrovirology; 2010 Dec; 7():114. PubMed ID: 21176220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.